Mark M. Davis

Mark M. Davis is the Burt and Marion Avery Family Professor of Immunology at Stanford University School of Medicine, where he serves as Professor of Microbiology and Immunology. He also holds prominent memberships in multiple Stanford institutes including Bio-X, the Cardiovascular Institute, the Maternal & Child Health Research Institute (MCHRI), the Stanford Cancer Institute, and the Wu Tsai Neurosciences Institute. Since 2004, he has directed the Stanford Institute for Immunity, Transplantation and Infection, and previously served as Chair of Microbiology and Immunology from 2002-2004.

His educational background includes a Ph.D. in Molecular Biology from Caltech (1981) and a B.A. in Molecular Biology from The Johns Hopkins University (1974).

Dr. Davis's research focuses on the molecular basis of T and B lymphocyte recognition and the control of differentiation and functional responses in these cells. His work spans from analyzing the inherent diversity of immune receptors and relating it to function and specificity to fundamental aspects of TCR biochemistry and cell biology. He pioneered the development of peptide-MHC tetramers, which have become essential tools for staining and isolating specific T cells in both basic science and clinical applications. His lab has also employed systems biology approaches to understand human immune responses to vaccines, twin studies examining environmental versus genetic influences on immunity, and T cell repertoire studies to understand self versus non-self recognition capabilities.

His recent publications demonstrate a strong focus on immunological responses to SARS-CoV-2 and COVID-19, examining antibody responses, T cell immunity, and immune correlates of disease severity and vaccine efficacy. His work also extends to understanding immune mechanisms in coronary artery disease, autoimmune disorders, and liver cirrhosis, revealing how basic immunological principles translate to diverse clinical conditions.

Dr. Davis has received numerous prestigious awards including election to both the National Academy of Sciences (1993) and National Academy of Medicine (2004), Foreign membership in The Royal Society (2017), the Paul Ehrlich Prize (2004), and the Gairdner Prize (1989), among many others.

As an advisor, Dr. Davis mentors numerous doctoral students, postdoctoral fellows, and medical scholars across multiple graduate programs including Biophysics, Immunology, and Microbiology and Immunology. His research is supported by multiple clinical trials focused on influenza vaccination responses across different age groups and in twins to understand genetic versus environmental influences on immunity, including longitudinal studies examining immune function decline in the elderly.

Dr. Davis leads a prominent immunology research laboratory at Stanford, where his team continues to develop innovative technologies that have become standard tools in immunology research. His leadership extends beyond his laboratory through directing the Stanford Institute for Immunity, Transplantation and Infection, which fosters interdisciplinary research across immunological sciences, connecting basic research with clinical applications.